NADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7
JCI Insight · 22.08.2024 · 9 (16)
DOI: 10.1172/jci.insight.178563 ↗Kurz gefasst
Fachartikel in der Zeitschrift JCI Insight, online erschienen am 23.07.2024. Verfasst von Rachael A Gordon und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Immunology and. Hauptthemen laut MEDLINE: Toll-Like Receptor 7, B-Lymphocytes, NADPH Oxidase 2, Macrophages. Die Arbeit wurde bisher 15-mal zitiert (Crossref) und nennt 111 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NIAMS NIH HHS, NIAID NIH HHS.
Abstract (Originalsprache)
Loss of NADPH oxidase (NOX2) exacerbates systemic lupus erythematosus (SLE) in mice and humans, but the mechanisms underlying this effect remain unclear. To identify the cell lineages in which NOX2 deficiency drives SLE, we employed conditional KO and chimeric approaches to delete Cybb in several hematopoietic cell lineages of MRL.Fas lpr SLE-prone mice. Deletion of Cybb in macrophages/monocytes exacerbated SLE nephritis, though not to the degree observed in the Cybb global KOs. Unexpectedly, the absence of Cybb in B cells resulted in profound glomerulonephritis and interstitial nephritis, rivaling that seen with global deletion. Furthermore, we identified that NOX2 is a key regulator of TLR7, a driver of SLE pathology, both globally and specifically in B cells. This is mediated in part through suppression of TLR7-mediated NF-κB signaling in B cells. Thus, NOX2’s immunomodulatory effect in SLE is orchestrated not only by its function in the myeloid compartment, but through a pivotal role in B cells by selectively inhibiting TLR7 signaling.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Immunology and.
- Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Immunobiology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA.
- Department of Pathology, Yale University School of Medicine, New Haven, Connecticut, USA.
- Departments of Medicine, Microbiology and Immunology, Biochemistry and Molecular Biology, State University of New York, Upstate Medical University, College of Medicine, Syracuse, New York, USA.
Förderung
- NIDDK NIH HHS
- NIAMS NIH HHS
- NIAID NIH HHS
- National Institutes of Health
Zitieren
APA
Gordon, R. A., Cosgrove, H. A., Marinov, A., Gingras, S., Tilstra, J. S., Campbell, A. M., Bastacky, S. I., Kashgarian, M., Perl, A., Nickerson, K. M., & Shlomchik, M. J. (2024). NADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7. JCI Insight, 9(16). https://doi.org/10.1172/jci.insight.178563
Vancouver
Gordon RA, Cosgrove HA, Marinov A, Gingras S, Tilstra JS, Campbell AM, et al. NADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7. JCI Insight. 2024;9(16). doi:10.1172/jci.insight.178563
BibTeX
@article{Gordon2024,
author = {Gordon, Rachael A and Cosgrove, Haylee A and Marinov, Anthony and Gingras, Sebastien and Tilstra, Jeremy S and Campbell, Allison M and Bastacky, Sheldon I and Kashgarian, Michael and Perl, Andras and Nickerson, Kevin M and Shlomchik, Mark J},
title = {NADPH oxidase in B cells and macrophages protects against murine lupus by regulation of TLR7},
journal = {JCI Insight},
year = {2024},
volume = {9},
number = {16},
doi = {10.1172/jci.insight.178563}
}
EUVIMED